- LDL particles carry cholesterol to your cells. When there are too many, they get trapped in artery walls and build plaque.
- Over 200 studies with about 2 million people show that LDL is a direct cause of heart attacks and strokes, not just a marker.
- Healthy targets depend on your risk: from under 116 mg/dL for low-risk people to under 55 mg/dL for those with heart disease.
- Every 39 mg/dL (1 mmol/L) drop in LDL cuts major heart events by about a fifth, and the benefit grows the longer LDL stays low.
If you have had a cholesterol test, LDL is probably the number your doctor looked at first. It is often called “bad” cholesterol, but that label hides a more useful story. LDL is not a poison. It is a delivery vehicle your body needs. The problem is volume and time: too many LDL particles, for too many years, slowly damage your arteries.
Our guide to understanding cholesterol numbers covers the whole lipid panel. This article goes deeper into LDL alone: what it does, how we know it causes heart disease, and what a healthy level looks like for you.
What LDL actually does
Cholesterol and fat cannot float freely in blood, so the liver packs them into tiny protein-wrapped particles called lipoproteins. LDL stands for low-density lipoprotein. Each LDL particle carries a load of cholesterol out to cells that need it to build membranes and make hormones. Cells take LDL in through “LDL receptors”, and the liver clears most of the rest from the blood.
When the liver makes too many particles, or clears them too slowly, LDL builds up in the blood. That is what your test measures as LDL cholesterol (LDL-C): the amount of cholesterol carried inside all your LDL particles.
LDL carries cholesterol to cells. Your body makes all the cholesterol it needs, so blood levels can be quite low and still be safe.
Genes, diet, weight and hormones change how many LDL receptors the liver makes, and so how fast LDL is cleared.
Extra LDL particles squeeze into artery walls, where they can get stuck and start plaque.
How LDL builds plaque
LDL particles are small enough to slip through the thin inner lining of an artery. Most slip back out. But the more LDL there is in the blood, the more particles get trapped. Once stuck, they are changed chemically, and immune cells rush in to swallow them. Those swollen cells form the fatty core of plaque. Over decades, plaque thickens, narrows the artery and can crack, triggering a clot that causes a heart attack or stroke.
From high LDL to a heart attack
Based on the European Atherosclerosis Society consensus, Ference et al., Eur Heart J 2017.
Proof that LDL causes heart disease
For years people argued that LDL was just linked with heart disease. That debate is largely settled. In 2017 the European Atherosclerosis Society reviewed over 200 studies covering about 2 million people, 20 million person-years of follow-up and 150,000 heart and stroke events. Three very different kinds of evidence gave the same answer:
- Population studies: the higher the LDL, the higher the risk, in a steady, dose-dependent way.
- Genetic studies: people born with gene variants that lower LDL have fewer heart attacks, and people born with variants that raise it have more.
- Clinical trials: medicines that lower LDL by different routes (statins, ezetimibe, PCSK9 inhibitors) all reduce events in proportion to how much LDL falls.
The panel concluded that LDL is a cause of atherosclerotic heart disease, and that the risk depends on both how high LDL is and how long you are exposed to it.
Healthy LDL levels depend on your risk
There is no single “normal” LDL. The European (ESC/EAS 2019) guideline sets targets according to your overall risk of a heart attack or stroke, which your doctor estimates from age, blood pressure, smoking, diabetes, kidney function and existing heart disease. The US (AHA/ACC 2018) guideline uses a similar risk-based approach.
| Your risk level | Examples | LDL goal (mg/dL) | LDL goal (mmol/L) |
|---|---|---|---|
| Low | Younger, no major risk factors | under 116 | under 3.0 |
| Moderate | Short-duration diabetes in younger adults, some risk factors | under 100 | under 2.6 |
| High | Diabetes for 10+ years, familial hypercholesterolemia, moderate kidney disease | under 70, and at least 50% lower than baseline | under 1.8 |
| Very high | Previous heart attack or stroke, diabetes with organ damage, severe kidney disease | under 55, and at least 50% lower than baseline | under 1.4 |
Mach et al., 2019 ESC/EAS guidelines for the management of dyslipidaemias. To convert, divide mg/dL by about 38.7 to get mmol/L.
Indian labs usually report mg/dL, while the UK and much of Europe use mmol/L. If your report says 3.4, it is mmol/L (about 131 mg/dL). Diabetes pushes many people straight into the high-risk group, which is why LDL targets for people with diabetes and heart disease are much lower.
Lower for longer
Plaque builds slowly, so what matters is your total lifetime exposure, a bit like years of sun on skin. A pooled analysis of 26 statin trials found that each 1 mmol/L (about 39 mg/dL) fall in LDL reduced major heart and stroke events by about 22% within roughly five years. Genetic studies, which reflect LDL that has been lower since birth, show a much larger effect per unit of LDL.
Cholesterol Treatment Trialists’ Collaboration, Lancet 2010; Ference et al., J Am Coll Cardiol 2012.
This is why healthy habits in your 30s and 40s pay off so well. A moderately lower LDL for decades may protect as much as a sharp drop started late in life.
How low is too low?
Many people worry that very low LDL is dangerous. Trials have tested this directly. In the IMPROVE-IT trial, people taking ezetimibe plus a statin reached an average LDL of about 54 mg/dL, versus about 70 mg/dL on a statin alone, and had fewer heart events. In the FOURIER trial, the PCSK9 inhibitor evolocumab took median LDL down to 30 mg/dL and cut the main outcome by 15%, with no increase in serious side effects over about two years. Cells can still get all the cholesterol they need at these levels.
Do not stop or change cholesterol medicine on your own. If you have side effects or questions about your target, talk to your doctor. Choices about medicines depend on your full risk picture.
What you can do
For most people, food and lifestyle changes can lower LDL by around 10–20%. The biggest levers are swapping saturated fat (ghee, butter, coconut oil, fatty meat) for unsaturated oils and nuts, eating more soluble fiber from oats, dal, rajma, chana and barley, and reaching a healthy weight. If your risk is high, medicine is usually added on top. Read our step-by-step guide on how to lower LDL cholesterol and see foods that lower cholesterol.
Know your wider risk. LDL is one piece of your metabolic picture. Try our Metabolic Health Score to see how your other numbers fit together.
MythIf your LDL is “normal” on the lab report, you have nothing to worry about.
FactLab reference ranges are general. If you have diabetes, kidney disease or past heart disease, your personal target may be far lower than the printed range.
Common questions
Is LDL cholesterol the same as LDL particles?
Not quite. LDL-C measures the cholesterol inside LDL particles. Usually the two move together, but sometimes people have many small particles carrying less cholesterol each. An apoB test counts particles more directly; see ApoB explained.
Can I have high LDL if I am slim and eat well?
Yes. Genes strongly influence how fast your liver clears LDL. An LDL of 190 mg/dL (4.9 mmol/L) or more may point to familial hypercholesterolemia, which needs medical care.
How fast can LDL come down?
Diet changes show results within about 4–6 weeks. Medicines work within a few weeks, which is why a repeat test is often done after 6–8 weeks.
- LDL particles carry cholesterol; too many of them cause artery plaque.
- Genetic, population and trial evidence agree that LDL is a cause of heart disease.
- Your LDL target depends on your risk, from under 116 mg/dL down to under 55 mg/dL.
- Lower LDL for longer gives the most protection, so start early.
- Next: HDL Cholesterol: Is “Good” Cholesterol Always Good?.
Sources
- Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459–2472.
- Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188.
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082–e1143.
- Cholesterol Treatment Trialists’ Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–1681.
- Ference BA, Yoo W, Alesh I, et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol. 2012;60(25):2631–2639.
- Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387–2397.
- Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713–1722.
This article is for general education and is not a substitute for advice from your own doctor or healthcare team.